THROMBOEMBOLIC PROTECTION FOR PATIENTS AT RISK OF THROMBOCYTOPENIA

Pharmaceuticals

Owner

CANYON PHARMACEUTICALS, INC.

—
IPREVASC

Pharmaceuticals

Owner

CANYON PHARMACEUTICALS, INC.

—
THROMBOEMBOLIC PROTECTION FOR PATIENTS AT RISK OF THROMBOCYTOPENIA

Pharmaceuticals

Owner

CANYON PHARMACEUTICALS, INC.

—